In a pre-planned secondary analysis of a placebo-controlled RCT in women with diminished ovarian reserve before IVF (213 of 288 analysed), transdermal testosterone did not improve fertility-related quality of life (Total FertiQoL P = 0.79) or any subscale.
Secondary analysisn = 213
Leathersich et al. The impact of transdermal testosterone treatment on quality of life in women with diminished ovarian reserve: secondary analysis of a randomized controlled trial